Advanced Biomed Inc.

Advanced Biomed Inc. (ADVB) priced its initial public offering on Mar 6, 2025 at $4.00 per share, within its $4.00–$6.00 range, raising $6.6M, and listed on Nasdaq Capital Market. At the IPO price its market capitalization was about $86.6M. VCL Law, Ortoli Rosenstadt, Fennemore Craig, Wiseteam Law Firm and AllBright advised the company.

Advanced Biomed Inc. is a Nevada holding company operating through Advanced Biomed Taiwan and Hong Kong subsidiaries. It applies semiconductor technology to biotechnology, using liquid biopsy to capture and identify circulating tumor cells and provide cancer patients with assay products and services.

Status

IPO

Ticker

ADVB

Exchange

Nasdaq Capital Market

Priced

Mar 6, 2025

IPO price

$4.00

Price range

$4.00–$6.00

Raised

$6.6M

Market cap at IPO price

$86.6M

First filed

May 22, 2023

Company counsel

VCL Law, Ortoli Rosenstadt, Fennemore Craig, Wiseteam Law Firm and AllBright

Sector

Healthcare

Country / state

NV

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.